3.
Hazard ratios (95% confidence intervals) for biochemical relapse after prostatectomy for established risk factors and PSP94/PTEN status
| Model | Scenario 4 | Scenario 3 | Scenario 2 | Scenario 1 | |
| * P ≤ 0.05, ** P ≤ 0.001, ***P ≤ 0.0001 | |||||
| Variable | Analyzable (n) | 5,127 | 5,206 | 5,267 | 3,283 |
| Gleason grade biopsy | ≥ 4+4 vs. ≤ 3+3 | 3.81 (3.25-4.46) *** | |||
| cT stage | T2c vs. T1c | 2.37 (1.81-3.06) *** | 2.27 (1.74-2.91) *** | ||
| Preoperative PSA level | ≥ 20 vs. < 4 | 3.46 (2.72-4.42) *** | 2.93 (2.30-3.74) *** | 2.04 (1.61-2.60) *** | 1.95 (1.49-2.61) *** |
| PSP94/PTEN status | Neg./del. vs. pos./norm. | 2.02 (1.70-2.40) *** | 1.71 (1.44-2.03) *** | 1.49 (1.26-1.77) *** | 1.36 (1.13-1.63) * |
| Gleason grade
prostatectomy |
≥ 4+4 vs. ≤ 3+3 | 11.2 (8.83-14.3) *** | 6.15 (4.76-7.96) *** | 4.51 (3.27-6.29) *** | |
| pT stage | T4 vs. T2 | 2.98 (2.55-3.48) *** | 2.85 (2.38-3.42) *** | ||
| Resection margin status | R1 vs. R0 | 1.41 (1.26-1.59) *** | 1.30 (1.13-1.48) ** | ||
| Nodal stage | N+ vs. N0 | 1.40 (1.18-1.67) ** | |||